IN8bio, Inc.
INAB
$1.55
-$0.11-6.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.09M | -5.55M | -6.16M | -7.09M | -8.63M |
| Total Depreciation and Amortization | 784.00K | 669.00K | 702.00K | 690.00K | 631.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 955.00K | 831.00K | 825.00K | 1.81M | 1.17M |
| Change in Net Operating Assets | -572.00K | 928.00K | 605.00K | -1.52M | 736.00K |
| Cash from Operations | -3.93M | -3.12M | -4.03M | -6.11M | -6.09M |
| Capital Expenditure | -- | -- | -33.00K | 0.00 | -83.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -33.00K | 0.00 | -83.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -234.00K | -225.00K | -219.00K | -213.00K | -174.00K |
| Issuance of Common Stock | 5.50M | 4.12M | 11.23M | 289.00K | 3.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 181.00K | -181.00K | 0.00 |
| Cash from Financing | 5.27M | 3.89M | 11.19M | -105.00K | 3.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.34M | 771.00K | 7.13M | -6.22M | -2.80M |